Last reviewed · How we verify
NCT06350604
Project WHADE: A Partner-Based Physical Activity Program for Women
NA trial testing Project WHADE: A Partner-Based Physical Activity Program for Women in Hypertension in 62 participants. Completed in 15 November 2024.
15 July 2024
Quick facts
| Lead sponsor | Rowan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 62 |
| Start date | 2 January 2024 |
| Primary completion | 15 July 2024 |
| Estimated completion | 15 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Project WHADE: A Partner-Based Physical Activity Program for Women
Conditions studied
- Hypertension — all drugs for Hypertension →
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Smoking — all drugs for Smoking →
Sponsor
Rowan University
Who can join
Adults 40 to 65, female only, with Hypertension or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to test the feasibility and acceptability of a new method for supporting physical activity among women ages 40-65 who have risk factors for cardiovascular disease. Each participant receives a trained physical activity coach and a physical activity partner; the partner is another woman in the program. Partners communicate with each other between weekly coaching sessions to provide support for physical activity behavior change.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Physical activity partners for women with cardiovascular disease risk: Proof-of-concept trial with daily assessment.
Arigo D, Baga K, Folk AL, Haggerty K. · · 2026 · cited 2× · PMID 41021523 · DOI 10.1037/hea0001554 -
Self-selected exercise goals during a broader physical activity intervention for women in midlife with elevated risk for cardiovascular disease: A mixed methods evaluation.
Benasi G, Salvatore GM, Mehta S, Rivera AR, et al · · 2026 · PMID 42102943 · DOI 10.1016/j.psychsport.2026.103152
Verify or expand the search:
- PubMed search for NCT06350604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Rowan University trials
Trials by the same sponsor.
- NCT07213388 — Immersive Virtual Reality vs Treadmill Exercise Project · NA · completed
- NCT06235463 — Pedal Pump and Leg Lymphedema · NA · recruiting
- NCT07256808 — Medial Tibial Stress Syndrome Prevention · NA · completed
- NCT06651671 — Tissue Changes Following Thoracic Myofascial Release · NA · completed
- NCT05224154 — Re-Connect Application for Smoking Cessation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06350604 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rowan University
- Last refreshed: 4 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06350604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing